Proteomic and Functional Analyses Reveal a Mitochondrial Dysfunction in P301L Tau Transgenic Mice*

Transgenic mice overexpressing the P301L mutant human tau protein exhibit an accumulation of hyperphosphorylated tau and develop neurofibrillary tangles. The consequences of tau pathology were investigated here by proteomics followed by functional analysis. Mainly metabolism-related proteins including mitochondrial respiratory chain complex components, antioxidant enzymes, and synaptic proteins were identified as modified in the proteome pattern of P301L tau mice. Significantly, the reduction in mitochondrial complex V levels in the P301L tau mice revealed using proteomics was also confirmed as decreased in human P301L FTDP-17 (frontotemporal dementia with parkinsonism linked to chromosome 17) brains. Functional analysis demonstrated a mitochondrial dysfunction in P301L tau mice together with reduced NADH-ubiquinone oxidoreductase activity and, with age, impaired mitochondrial respiration and ATP synthesis. Mitochondrial dys-function was associated with higher levels of reactive oxygen species in aged transgenic mice. Increased tau pathology as in aged homozygous P301L tau mice revealed modified lipid peroxidation levels and the up-regulation of antioxidant enzymes in response to oxidative stress. Furthermore, P301L tau mitochondria displayed increased vulnerability toward β-amyloid (Aβ) peptide insult, suggesting a synergistic action of tau and Aβ pathology on the mitochondria. Taken together, we conclude that tau pathology involves a mitochondrial and oxidative stress disorder possibly distinct from that caused by Aβ.

[1]  T. Bayer,et al.  Impaired Cu/Zn-SOD activity contributes to increased oxidative damage in APP transgenic mice , 2005, Neurobiology of Disease.

[2]  P. Greengard,et al.  Different Presynaptic Roles of Synapsins at Excitatory and Inhibitory Synapses , 2004, The Journal of Neuroscience.

[3]  C. Haass,et al.  Amyloid β-induced Changes in Nitric Oxide Production and Mitochondrial Activity Lead to Apoptosis* , 2004, Journal of Biological Chemistry.

[4]  L. Landino,et al.  Redox modulation of tau and microtubule-associated protein-2 by the glutathione/glutaredoxin reductase system. , 2004, Biochemical and biophysical research communications.

[5]  A. Drzezga,et al.  Cerebral metabolic patterns at early stages of frontotemporal dementia and semantic dementia. A PET study , 2004, Neurobiology of Aging.

[6]  Armin Scheurich,et al.  Association of elevated phospho-tau levels with alzheimer-typical 18F-Fluoro-2-Deoxy-D-Glucose positron emission tomography findings in patients with mild cognitive impairment , 2004, Biological Psychiatry.

[7]  L. Landino,et al.  Cysteine Oxidation of Tau and Microtubule-associated Protein-2 by Peroxynitrite , 2004, Journal of Biological Chemistry.

[8]  M. Beal,et al.  Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[9]  J. Streffer,et al.  Transgenic animal models of Alzheimer's disease and related disorders: histopathology, behavior and therapy , 2004, Molecular Psychiatry.

[10]  A. Drzezga,et al.  Region-Specific Decline of Cerebral Glucose Metabolism in Patients with Frontotemporal Dementia: A Prospective 18F-FDG-PET Study , 2004, Dementia and Geriatric Cognitive Disorders.

[11]  N. Cairns,et al.  Impact of gender on upregulation of antioxidant defence mechanisms in Alzheimer’s disease brain , 2004, Journal of Neural Transmission.

[12]  R. Nitsch,et al.  Accelerated extinction of conditioned taste aversion in P301L tau transgenic mice , 2004, Neurobiology of Disease.

[13]  Eden R Martin,et al.  Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease. , 2003, Human molecular genetics.

[14]  T. Bayer,et al.  Time sequence of maturation of dystrophic neurites associated with Aβ deposits in APP/PS1 transgenic mice , 2003, Experimental Neurology.

[15]  D. Butterfield,et al.  Proteomics in Alzheimer's disease: insights into potential mechanisms of neurodegeneration , 2003, Journal of neurochemistry.

[16]  J. Trojanowski,et al.  Enhanced brain levels of 8,12-iso-iPF2α-VI differentiate AD from frontotemporal dementia , 2003, Neurology.

[17]  Richard F. Thompson,et al.  Reversal of age-related learning deficits and brain oxidative stress in mice with superoxide dismutase/catalase mimetics , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Visith Thongboonkerd,et al.  Proteomic identification of nitrated proteins in Alzheimer's disease brain , 2003, Journal of neurochemistry.

[19]  E. R. Taylor,et al.  Reversible Glutathionylation of Complex I Increases Mitochondrial Superoxide Formation* , 2003, Journal of Biological Chemistry.

[20]  M. Robin,et al.  Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells , 2003, The Journal of cell biology.

[21]  A. Delacourte,et al.  Association of atp synthase α-chain with neurofibrillary degeneration in alzheimer’s disease , 2003, Neuroscience.

[22]  T. Russo,et al.  Signal Transduction through Tyrosine‐Phosphorylated Carboxy‐Terminal Fragments of APP via an Enhanced Interaction with Shc/Grb2 Adaptor Proteins in Reactive Astrocytes of Alzheimer's Disease Brain , 2002, Annals of the New York Academy of Sciences.

[23]  Xiongwei Zhu,et al.  The p38 pathway is activated in Pick disease and progressive supranuclear palsy: a mechanistic link between mitogenic pathways, oxidative stress, and tau , 2002, Neurobiology of Aging.

[24]  K. Kaibuchi,et al.  CRMP-2 binds to tubulin heterodimers to promote microtubule assembly , 2002, Nature Cell Biology.

[25]  G. Sobue,et al.  Lipid peroxidation and advanced glycation end products in the brain in normal aging and in Alzheimer's disease , 2002, Acta Neuropathologica.

[26]  Peter Lipp,et al.  Mitochondria are morphologically and functionally heterogeneous within cells , 2002, The EMBO journal.

[27]  J. Land,et al.  β‐Amyloid inhibits integrated mitochondrial respiration 
and key enzyme activities , 2001, Journal of neurochemistry.

[28]  R. Faull,et al.  Proteomic analysis of the brain in Alzheimer’s disease: Molecular phenotype of a complex disease process , 2001, Proteomics.

[29]  R. Nitsch,et al.  Formation of Neurofibrillary Tangles in P301L Tau Transgenic Mice Induced by Aβ42 Fibrils , 2001, Science.

[30]  K. Kaibuchi,et al.  CRMP-2 induces axons in cultured hippocampal neurons , 2001, Nature Neuroscience.

[31]  N. Cairns,et al.  The reduction of NADH ubiquinone oxidoreductase 24- and 75-kDa subunits in brains of patients with Down syndrome and Alzheimer's disease. , 2001, Life sciences.

[32]  B. Winblad,et al.  The Cerebrocortical Areas in Normal Brain Aging and in Alzheimer's Disease: Noticeable Differences in the Lipid Peroxidation Level and in Antioxidant Defense , 2001, Neurochemical Research.

[33]  N. Cairns,et al.  Deranged expression of molecular chaperones in brains of patients with Alzheimer's disease. , 2001, Biochemical and biophysical research communications.

[34]  R. Nitsch,et al.  Tau Filament Formation in Transgenic Mice Expressing P301L Tau* , 2001, The Journal of Biological Chemistry.

[35]  I. Lemahieu,et al.  Differential Regional Cerebral Uptake of 18F-Fluoro-2-Deoxy-D-Glucose in Alzheimer’s Disease and Frontotemporal Dementia at Initial Diagnosis , 2001, European Neurology.

[36]  G. Perry,et al.  Phosphorylated, but not native, tau protein assembles following reaction with the lipid peroxidation product, 4‐hydroxy‐2‐nonenal , 2000, FEBS letters.

[37]  M. Kinoshita,et al.  Differential localization of septins in the mouse brain , 2000, The Journal of comparative neurology.

[38]  Wen-Lang Lin,et al.  Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein , 2000, Nature Genetics.

[39]  E B Mukaetova-Ladinska,et al.  Staging of cytoskeletal and beta-amyloid changes in human isocortex reveals biphasic synaptic protein response during progression of Alzheimer's disease. , 2000, The American journal of pathology.

[40]  M. Radermacher,et al.  Biophysical and structural characterization of proton-translocating NADH-dehydrogenase (complex I) from the strictly aerobic yeast Yarrowia lipolytica. , 2000, Biochimica et biophysica acta.

[41]  U. F. Rasmussen,et al.  Human quadricepts muscle mitochondria: A functional characterization , 2000, Molecular and Cellular Biochemistry.

[42]  S. Menini,et al.  Lipoperoxidation Is Selectively Involved in Progressive Supranuclear Palsy , 2000, Journal of neuropathology and experimental neurology.

[43]  Luis Moroder,et al.  Structure of TPR Domain–Peptide Complexes Critical Elements in the Assembly of the Hsp70–Hsp90 Multichaperone Machine , 2000, Cell.

[44]  M. Goedert,et al.  Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) , 2000, Neurogenetics.

[45]  J. Kovács,et al.  Enhanced association of mutant triosephosphate isomerase to red cell membranes and to brain microtubules. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[46]  C. Culmsee,et al.  Cellular and Molecular Mechanisms Underlying Perturbed Energy Metabolism and Neuronal Degeneration in Alzheimer's and Parkinson's Diseases , 1999, Annals of the New York Academy of Sciences.

[47]  J. Prehn,et al.  Mitochondrial Depolarization Is Not Required for Neuronal Apoptosis , 1999, The Journal of Neuroscience.

[48]  D. Butterfield,et al.  The Expression of Several Mitochondrial and Nuclear Genes Encoding the Subunits of Electron Transport Chain Enzyme Complexes, Cytochrome c Oxidase, and NADH Dehydrogenase, in Different Brain Regions in Alzheimer's Disease , 1999, Neurochemical Research.

[49]  R. Bowser,et al.  The septin CDCrel-1 binds syntaxin and inhibits exocytosis , 1999, Nature Neuroscience.

[50]  Mark A. Smith,et al.  Signal transduction abnormalities in Alzheimer's disease: evidence of a pathogenic stimuli , 1999, Brain Research.

[51]  C Xie,et al.  Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimer's disease , 1998, Neurology.

[52]  E. Mandelkow,et al.  Overexpression of Tau Protein Inhibits Kinesin-dependent Trafficking of Vesicles, Mitochondria, and Endoplasmic Reticulum: Implications for Alzheimer's Disease , 1998, The Journal of cell biology.

[53]  A Klug,et al.  Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[54]  Ronald C. Petersen,et al.  Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17 , 1998, Nature.

[55]  G. Schellenberg,et al.  Tau is a candidate gene for chromosome 17 frontotemporal dementia , 1998, Annals of neurology.

[56]  H. Akiyama,et al.  Identification of septins in neurofibrillary tangles in Alzheimer's disease. , 1998, The American journal of pathology.

[57]  G. Davey,et al.  Energy Thresholds in Brain Mitochondria , 1998, The Journal of Biological Chemistry.

[58]  D. Hochstrasser,et al.  Extraction of membrane proteins by differential solubilization for separation using two‐dimensional gel electrophoresis , 1998, Electrophoresis.

[59]  Y. Ihara,et al.  Collapsin Response Mediator Protein-2 Is Associated with Neurofibrillary Tangles in Alzheimer’s Disease* , 1998, The Journal of Biological Chemistry.

[60]  M. Freedman,et al.  Increased Peroxidation and Reduced Antioxidant Enzyme Activity in Alzheimer's Disease , 1998, Experimental Neurology.

[61]  J. Kocsis,et al.  Peripheral Axotomy Induces Long-Term c-Jun Amino-Terminal Kinase-1 Activation and Activator Protein-1 Binding Activity by c-Jun and junD in Adult Rat Dorsal Root Ganglia In Vivo , 1998, The Journal of Neuroscience.

[62]  S. Budd,et al.  Mitochondrial membrane potential and hydroethidine‐monitored superoxide generation in cultured cerebellar granule cells , 1997, FEBS letters.

[63]  M. Mattson,et al.  Impairment of Glucose and Glutamate Transport and Induction of Mitochondrial Oxidative Stress and Dysfunction in Synaptosomes by Amyloid β‐Peptide: Role of the Lipid Peroxidation Product 4‐Hydroxynonenal , 1997, Journal of neurochemistry.

[64]  Mark A. Smith,et al.  4‐Hydroxynonenal‐Derived Advanced Lipid Peroxidation End Products Are Increased in Alzheimer's Disease , 1997, Journal of neurochemistry.

[65]  R. DeTeresa,et al.  Neurofibrillary tangle-associated alteration of stathmin in Alzheimer's disease , 1996, Neurobiology of Aging.

[66]  G. Davey,et al.  Threshold Effects and Control of Oxidative Phosphorylation in Nonsynaptic Rat Brain Mitochondria , 1996, Journal of neurochemistry.

[67]  W. D. Ehmann,et al.  Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease , 1995, Neurology.

[68]  H. Schägger,et al.  Human diseases with defects in oxidative phosphorylation. 2. F1F0 ATP-synthase defects in Alzheimer disease revealed by blue native polyacrylamide gel electrophoresis. , 1995, European journal of biochemistry.

[69]  M. Beal,et al.  Cortical Cytochrome Oxidase Activity Is Reduced in Alzheimer's Disease , 1994, Journal of neurochemistry.

[70]  M. Beal,et al.  Marked changes in mitochondrial DNA deletion levels in Alzheimer brains. , 1994, Genomics.

[71]  M. Mattson,et al.  A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[72]  C. Nebot,et al.  Spectrophotometric assay of superoxide dismutase activity based on the activated autoxidation of a tetracyclic catechol. , 1993, Analytical biochemistry.

[73]  I. Ceballos-Picot,et al.  4-Hydroxynonenal content lower in brains of 25 month old transgenic mice carrying the human CuZn superoxide dismutase gene than in brains of their non-transgenic littermates. , 1993, Journal of lipid mediators.

[74]  B. Crain,et al.  Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients. , 1993, Genomics.

[75]  D. Price,et al.  Age‐Dependent Impairment of Mitochondrial Function in Primate Brain , 1993, Journal of neurochemistry.

[76]  W. Müller,et al.  Age-related deficits of central muscarinic cholinergic receptor function in the mouse: Partial restoration by chronic piracetam treatment , 1992, Neurobiology of Aging.

[77]  W. Jagust,et al.  Diminished Glucose Transport in Alzheimer's Disease: Dynamic PET Studies , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[78]  M. Brammer,et al.  Brain membrane fluidity and lipid peroxidation in Alzheimer's disease , 1990, Neuroscience Letters.

[79]  D. Neary,et al.  Mitochondrial function in brain tissue in primary degenerative dementia , 1987, Brain Research.

[80]  M. Comporti Glutathione depleting agents and lipid peroxidation. , 1987, Chemistry and physics of lipids.

[81]  D. Neary,et al.  AN ULTRASTRUCTURAL ANALYSIS OF THE EFFECTS OF ACCUMULATION OF NEUROFIBRILLARY TANGLE IN PYRAMIDAL NEURONS OF THE CEREBRAL CORTEX IN ALZHEIMER'S DISEASE , 1986, Neuropathology and applied neurobiology.

[82]  K. Ohta,et al.  Regional Distributions of Thiobarbituric Acid‐Reactive Products, Activities of Enzymes Regulating the Metabolism of Oxygen Free Radicals, and Some of the Related Enzymes in Adult and Aged Rat Brains , 1986, Journal of neurochemistry.

[83]  F. Ursini,et al.  The selenoenzyme phospholipid hydroperoxide glutathione peroxidase. , 1985, Biochimica et biophysica acta.

[84]  J. Gutteridge,et al.  Lipid peroxidation initiated by superoxide‐dependent hydroxyl radicals using complexed iron and hydrogen peroxide , 1984, FEBS letters.

[85]  J. Gutteridge,et al.  Superoxide-dependent lipid peroxidation. Problems with the use of catalase as a specific probe for fenton-derived hydroxyl radicals. , 1983, Biochemical and biophysical research communications.

[86]  J. Turrens,et al.  Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria. , 1980, The Biochemical journal.

[87]  W. Valentine,et al.  Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. , 1967, The Journal of laboratory and clinical medicine.

[88]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[89]  J. Trojanowski,et al.  Expression of the small heat-shock protein alphaB-crystallin in tauopathies with glial pathology. , 2004, The American journal of pathology.

[90]  R. Kozłowski,et al.  The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity. , 1993, Journal of immunological methods.

[91]  H. Esterbauer,et al.  Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. , 1990, Methods in enzymology.

[92]  P. Tarroux,et al.  Improvement and simplification of low‐background silver staining of proteins by using sodium dithionite , 1988, Electrophoresis.